Charity expresses concern over ‘decline' in stroke after-care

A new snapshot poll of stroke care found that just under a quarter (24.8%) of stroke patients received a speech and language therapy (SLT) assessment within 24 hours of arrival at hospital, and less than half get this check within 72 hours.
The Stroke Association said that around a third of stroke survivors will suffer aphasia – a language and communication disability, which leaves people struggling to speak, read, write or understand language.
⚠️Every day in May, 240 people will wake up to the life-changing impact of a stroke
This #StrokeAwarenessMonth, help raise awareness of the impact of stroke so that the Stroke Association can help more people find strength through support.
➡️https://t.co/K3MVhancVT pic.twitter.com/VZyJpg3ehW
— North East and North Cumbria NHS (@NENC_NHS) May 7, 2025
And speech and language therapy is most effective the sooner it is delivered after a stroke, it said.
But according to its easement of the latest data from the Sentinel Stroke National Audit Programme (SSNAP), the amount of time spent delivering speech and language therapy in hospital has declined by 10% in the last five years.
It is recommended that rehabilitation after a stroke which also includes physiotherapy and occupational therapy should be provided for a minimum of three hours a day, five times a week in the aftermath of a stroke.
However the charity said that data from the audit – which covers England, Wales and Northern Ireland – from October to December last year suggests that just over a third (35%) are getting the recommended levels of support.
The charity is calling for all stroke patients to get the recommended levels of speech and language therapy.
It is also calling for stroke survivors to have a six-month review after the figures suggest that only 39% were given this 'vital' assessment in the last three months to 2024.
Juliet Bouverie, chief executive of the Stroke Association, said: 'It is unacceptable that vital speech and language therapy assessments for stroke survivors have declined in recent years.
'Losing the ability to communicate after a stroke can be one of the scariest and most unsettling aspects in the early stages after a stroke.
'In the long-term, speech and language therapy plays a huge part in boosting a stroke survivor's overall quality of life to support good mental health by helping to ensure they can enjoy the simple pleasure of communication.
'Whilst the skill, effort and true dedication of the NHS workforce cannot be questioned, there is a real and urgent need to recruit, train and retain more staff who can provide rehabilitation tailored to the needs of individual stroke survivors for as long as they need it.'
Kelly Williams, 55, from Birmingham had two strokes in 2017 which left her with aphasia and unable to say her own name for three years.
She said that it was 'days 'before she received her speech and language assessment in hospital and that she did not have any speech therapy in hospital at all.
Kelly Williams, 55, from Birmingham had two strokes in 2017 and said it was 'days' before she received a speech and language assessment (Stroke Association/PA)
She also had to wait until she was given care in the community.
'I knew nothing about what was happening to me, my family were confused because they didn't know how to communicate with me,' said Ms Williams.
'What I needed was someone to tell me that I had aphasia, what that meant, and what I could do about it – but no one did.
'I am so grateful for my care from NHS staff, but it upsets me when I see so many people struggling, especially those who have received little or no help from speech and language therapy – those assessments are vital.'
A Welsh Government spokesperson said it funds multi-professional rehabilitation support workers with £200,000 each year, adding: 'All health boards in Wales provide specialist speech and language therapy services for people with a range of conditions, including stroke.'
A Department of Health and Social Care spokesperson said: 'We are committed to improving stroke prevention, treatment, and recovery through our 10 Year Health Plan, including making sure we have the right staff in the right place to deliver the care patients need when they need it.'
A spokesperson for the Department of Health Northern Ireland added: 'The Stroke Action Plan recognises that there are pressures within the stroke service and the stroke workforce, whilst recognising the huge efforts made by all staff to provide high quality care.
'The department is currently progressing a stroke workforce review which is tasked with planning for a stroke workforce of the right size, with the right skills, deployed in the right way to deliver safe, effective and quality stroke services, based on data, evidence and analysis of current and future population health needs.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Mirror

22 minutes ago

• Daily Mirror

NHS urges many people between 25 and 64 to put on key phone alert

Invitations to specific health examinations are now being issued through the NHS mobile app - here's what you need to know Certain Android and iPhone users aged 25 and 64 are encouraged to download the NHS app for important updates. This specifically regards women, trans people and anyone else with a cervix, which describes the neck of the uterus. This morning, the NHS issued a crucial alert about its mobile app on X, formerly Twitter. It stressed: "Cervical screening invitations are now being sent through the NHS App for women and people with a cervix between the ages of 25 and 64. ‌ "One - Download the NHS App. Two - Turn on notifications. Three - Book and attend your appointment, when invited." Cervical screenings, commonly called smear tests, are conducted to assess the health of the cervix and aid in preventing cancer. ‌ Generally, the examination takes around five minutes and involves undressing from the waist down before lying on a bed. A nurse will then insert a tube-shaped speculum into the vagina and expand it to visualise the cervix, from which cell samples will be collected using a small brush. Medical professionals are particularly interested in types of 'human papillomavirus (HPV)', a widespread group of viruses that may lead to changes in the cervix. HPV spreads through multiple means, including sexual activity, skin-to-skin contact in the genital area, and sharing sex toys. Although the body can eliminate HPV without difficulty, certain types may persist for an extended period. In severe instances, high-risk HPV types could lead to genital warts or cervical cancer. "Cervical screening checks the health of your cervix and helps find any abnormal changes before they can turn into cancer," further NHS guidance explains. "It's not a test for cancer, it's a test to help prevent cancer. Cervical screening checks a sample of cells from your cervix for certain types of human papillomavirus (HPV). "These types of HPV can cause abnormal changes to the cells in your cervix and are called 'high risk' types of HPV. If high-risk types of HPV are found during screening, the sample of cells is also checked for abnormal cell changes. If abnormal cells are found, they can be treated so they do not get a chance to turn into cervical cancer." ‌ While 25 to 49-year-olds are typically invited to take a screening every three years, 50 to 64-year-olds are invited every five years. Anyone aged 65 or above may be asked if a recent examination was abnormal. Invitations are sent through the NHS app, as well as via text or mail. Am I at risk of cervical cancer? People with a cervix might be at risk of cervical cancer if they have engaged in 'any kind of sexual contact'. This includes: ‌ Vaginal, oral or anal sex Any skin-to-skin contact with the genital area Sharing sex toys This also applies in the following cases: You have only ever had one sexual partner, or you've had the same partner for a long time You are lesbian or bisexual You are a trans man with a cervix You have received the HPV vaccine You have undergone a partial hysterectomy that did not remove all of your cervix

Daily Record

22 minutes ago

• Daily Record

Who is eligible for Mounjaro as weight loss jab becomes available from GPs?

Here's who will be able to get Mounjaro, that treats types 2 diabetes and aids weight loss, on the NHS Weight-loss injections have surged in popularity over the last couple of years, fuelled by celebrity endorsements and social media exposure. And one jab that's capturing public attention and dominating headlines is Mounjaro. Tirzepatide, to give the treatment its medical name, is a prescription injectable medication designed to help adults with type 2 diabetes better manage their blood sugar levels. ‌ When combined with a healthy diet and regular exercise, it can significantly improve glucose control, supporting a more balanced approach to diabetes management. ‌ While originally developed to manage type 2 diabetes, Mounjaro has been licensed in the UK to treat obesity since November 2024, and is effective in helping patients achieve significant weight loss. Mounjaro received approval from NICE (National Institute for Health and Care Excellence) for treating obesity in England, Wales and Northern Ireland. Scotland had already approved Tirzepatide for obesity treatment through the Scottish Medicines Consortium, leading the way in making this medication available to patients. But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as the health service begins its mass rollout. Some 220,000 people with the "greatest need" are expected to receive Mounjaro, made by pharmaceutical company Lilly, through the NHS over the next three years. ‌ So, amid the recent change, who is actually eligible for Mounjaro? According to NHS England, the first group of patients who will be able to get the jab from their GP or a community clinic, will be those most in need. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as: type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. ‌ It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems. People will also get "wrap-around" care - including support with exercising and following a healthy diet, for example. But prescriptions for the drug will not necessarily be available from all local GPs, according to the BBC. In some cases, they will come from other primary care services. ‌ Some GP practices have issued notices on their websites saying very few patients on their lists, external will qualify for the medicine straight away and if anyone doesn't meet the criteria, they should not book an appointment. What's more, according to the Company Chemists' Association, the trade association for large pharmacies, it is not looking too promising that all patients who want Mounjaro and meet the criteria will get it straight away. Chief executive Malcolm Harrison said "it is unlikely that the planned GP provision will be sufficient to meet patient demand". ‌ The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says. Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News has established. Here, health boards make decisions on which medicines are available in their areas. In the same breath that we talk about people who are eligible for Mounjaro, there are groups who cannot take it. Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS. For those taking the contraceptive pill and using Tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. Join the Daily Record WhatsApp community!

BBC News

29 minutes ago

• BBC News

National investigation into maternity care announced

Health Secretary Wes Streeting has announced a national investigation into maternity care in "rapid" inquiry will urgently look at the worst-performing maternity and neonatal services in the country, including Leeds, Sussex, Gloucester, and Mid and South has met parents who have lost babies in a series of maternity scandals at some NHS trusts and said the investigation would "make sure these families get the truth and the accountability they deserve". It will begin this summer and report back by December 2025. The review will look across the entire maternity system, bringing together the findings of past reviews into a clear national set of actions to ensure every woman and baby receives safe, high-quality and compassionate the announcement on Monday, Streeting apologised on behalf of the NHS to those families who had suffered avoidable comes after a series of maternity scandals, including in Morecambe Bay, East Kent, Shrewsbury and Telford and said the review would be co-produced with the victims of maternity scandals, giving families a voice into how the inquiry is said he wants to ensure "no parent or baby is ever let down again".